#7245 Cancer Treatment Related Cognitive Impairment
With the increase of oncology survival rates, the need for a succinct path to survivorship and return to a “new normal” is critical. Oncology professionals have identified that Chemotherapy Related Cognitive Impairment (CRCI) is a common side effect of cancer treatment, impacting as many as 75% of survivors. For Speech-Language Pathologists, cognition is a key component in the scope of practice, yet the profession has been silent in establishing their role in the treatment of this occurrence. This presentation will shed light on the various physical causes and rationale behind CRCI, clinical symptoms that are present in the general patient population, therapeutic suggestions for the treatment of CRCI, proper documentation, and billing information for reimbursement.
Instructor: Kara Skelley, M.A. CCC-SLP,
Live Webinar Dates and Times:
None scheduled at this time.
3 hours or .3 or 3 CEUs